Soleo Health adds new drug
By HME News Staff
Updated 9:17 AM CST, Tue December 22, 2020
FRISCO, Texas – Soleo Health, a provider of complex specialty pharmacy and infusion services, is now offering SEVENFACT, a newly released drug by HEMA Biologics for the treatment and control of bleeding disorders in adolescent and adult patients with Hemophilia A or B with inhibitors. Soleo Health is among the first to offer the drug, which was approved by the U.S. Food and Drug Administration in April and which was made available to the marketplace on Dec. 10. “Soleo Health is on the cutting edge in terms of forging manufacturer relationships and bringing the latest in clinical advancements to our patients and prescribing physicians,” said Craig Vollmer, chief commercial officer. “We continue to enhance and expand our portfolio by including new pharmaceutical treatments.” Soleo Health operates 20 locations throughout the U.S. with national nursing coverage and pharmacy licensure in 50 states.
Comments